Skip to main content
v2026.11,986 entries · CC-BY 4.0

Editorial · CASRAI · Funding lifecycle and financial vocabulary

Springer Nature raises 2026 outlook as research articles grow 12% and transformative deals reach 105

Springer Nature’s nine-month results show 6.3% revenue growth, 12% more research articles and 105 transformative agreements, and a raised 2026 outlook.

Published 17 Nov 2026· 7 minute read

Ask CASRAI · free to try

Ask about this story

2 free questions a day, no account.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

CASRAI is the reference for research administration — bookmark it for the next question.

Springer Nature reported on 17 November 2026 that group revenue rose 6.3% on an underlying basis to €1,469.3 million in the first nine months of the year, and raised its full-year outlook to underlying revenue growth of at least 6%. The publisher said its research article output grew about 12%, against estimated market growth of about 8%, a figure that bears on article processing charges and transformative agreements for libraries and research offices.

What happened

In its nine-month 2026 results release, published on 17 November 2026 from Berlin under the headline “Strong performance in the first nine months, led by momentum in Research. 2026 outlook updated,” Springer Nature reported group revenue of €1,469.3 million (nine months 2025: €1,428.7 million), with 6.3% underlying growth. Adjusted operating profit (AOP) was €427.8 million (nine months 2025: €408.3 million), up 7.7% on an underlying basis, with the underlying margin improving by 36 basis points. Free cash flow rose by €69.1 million to €243.6 million, and net financial debt stood at €1,200 million at 30 September 2026, a leverage ratio of 1.6x, within the company’s 1.5–2.0x target range.

Chief executive Frank Vrancken Peeters said in the release: “Our performance in the first nine months of 2026 was again led by the Research segment.” The company also reported that Patric Somlo joined as chief financial officer on 3 November 2026.

Key details

The Research segment, which publishes the company’s journals and books for researchers, drove the result. The release gives these figures for the segment and its sister segments:

Segment Revenue, 9M 2026 Underlying revenue growth AOP, 9M 2026 Underlying AOP growth
Research €1,145.4 million 7.4% €369.0 million 8.4%
Health €134.9 million 0.5% €25.8 million 0.7%
Education €190.2 million 4.4% €32.9 million 4.9%

On publishing volume, the release says published research articles rose about 12%, against estimated market growth of about 8%, with growth across the fully open access, Nature and Springer journal portfolios. The headline for the Journals business credits “leadership in open access.” Springer Nature launched 54 new journals in the year to September, including 17 titles in its Discover portfolio.

On agreements, the company signed 23 new transformative agreements during the period, bringing the total to 105, covering more than 4,500 institutions. Research Information, summarising the release, reports that Springer Nature has completed its 2026 contract renewals and that negotiations for the next cycle, which began in September, are progressing as expected.

The outlook changed for the second time this year. In March the company expected underlying revenue growth of 5–6% with an underlying AOP margin increase of around 30 basis points. In August it moved to growth of around 6% with a margin increase of at least 30 basis points. It now expects underlying revenue growth of at least 6% and a margin increase of at least 30 basis points.

Background and context

Gold open access journals charge an article processing charge (APC) that a funder, library or author pays when an article is accepted, while hybrid journals mix subscription content with open articles. Transformative agreements are the contracts through which a consortium or institution folds subscription spending and open access publishing fees into a single arrangement, so that corresponding authors at member institutions can publish open access without paying individual APCs. Springer Nature’s reporting therefore reads as a measure of how much of the world’s publishing capacity is being routed through APC-funded and agreement-funded open access.

The August half-year release, published on 5 August 2026 under the headline “Strong H1 performance led by momentum in Research. 2026 outlook updated,” reported group revenue of €939.8 million with 6.2% underlying growth, and the company said it had signed 19 transformative agreements in that half-year. The nine-month figures extend the same trend: Research growth of 7.4% sits above the 6.3% group rate, and article output is growing faster than the market. For earlier CASRAI coverage of how Springer Nature’s open access publishing is being used and cited, see Springer Nature: China’s gold OA articles now draw 40% of citations from abroad.

Technology and portfolio changes

The release also reports on the AI-enabled tooling around the editorial process. More than 62% of submissions were processed through SNAPP, Springer Nature’s integrated publishing platform, and the company says AI is being used to strengthen research integrity, although the release names no specific integrity measures. Its Nature Research Assistant is in beta with more than 25,000 users and is scheduled to launch in early 2027, with customer satisfaction scores above 80% for the tools reported, including Manuscript Adviser, introduced earlier in 2026. The company also said its ARC3 licensing partnerships, which let corporate customers use scientific content inside AI-powered environments, continued to progress.

On portfolio, Springer Nature completed the sale of Scientific American to LabX Media Group on 24 June 2026 and of Spektrum to GeraNova Bruckmann on 31 July 2026. The company said the disposed business contributed about €25 million to 2025 Research revenue and is expected to be slightly accretive to AOP.

Reaction

Research Information, headlining its report “Springer Nature reports growth as OA and AI drive research publishing,” led with the growth in research article output relative to the market and the expansion of institutional publishing agreements internationally. Investing.com, covering the investor presentation slides, described the update as research strength driving an upgraded outlook. It reported that management does not expect significant revenue from the Nature Research Assistant next year and is focusing on user growth first, that foreign exchange is a headwind to reported growth, and that the 2027 renewal season has started in line with expectations. The same report flagged possible changes to US federal funding as a factor that could affect how researchers pay publishing costs; that point is the outlet’s reading of the presentation rather than a statement in the company’s release.

What it means for researchers, universities and research offices

For research offices and libraries that fund APCs, the practical signal is volume. A publisher growing article output at about 12% a year while market growth is about 8% is taking share, and a large part of that growth is attributed to open access journals. Budget holders should expect continued pressure on APC and agreement spending lines and should check that their institution’s author-facing guidance reflects which journals fall under an existing agreement.

For libraries and consortia, 105 agreements covering more than 4,500 institutions mean that most large research-intensive institutions in participating countries already sit under a Springer Nature agreement or are negotiating one. The 2027 renewal cycle, which began in September, is the point at which terms, caps and eligible journal lists are set. Offices preparing for it can use their own data on corresponding-author output, APC payments outside agreements and hybrid journal usage to test whether current terms match actual publishing behaviour.

For researchers, the company’s statement that more than 62% of submissions now pass through SNAPP means a majority of manuscripts to Springer Nature journals are handled by an AI-enabled platform during intake and screening. Authors with questions about how tools such as Manuscript Adviser or the forthcoming Nature Research Assistant treat submitted text should read the relevant journal and tool terms before use.

What happens next

Springer Nature held an investor and analyst call at 14:00 CET on 17 November 2026, with details at its investor relations site. Negotiations for the 2027 agreement cycle are under way, the Nature Research Assistant is scheduled to launch in early 2027, and the company’s full-year 2026 results will confirm whether the raised outlook of at least 6% underlying revenue growth is met.

Sources

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →